WO2002003910A3 - Preparation antibacterienne, anticancerigene, antioxydante et immunomodulatrice et procede d'utilisation - Google Patents
Preparation antibacterienne, anticancerigene, antioxydante et immunomodulatrice et procede d'utilisation Download PDFInfo
- Publication number
- WO2002003910A3 WO2002003910A3 PCT/RU2001/000276 RU0100276W WO0203910A3 WO 2002003910 A3 WO2002003910 A3 WO 2002003910A3 RU 0100276 W RU0100276 W RU 0100276W WO 0203910 A3 WO0203910 A3 WO 0203910A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- preparation
- liquid
- immunomoduling
- anticancerogenic
- antibacterial
- Prior art date
Links
- 230000000844 anti-bacterial effect Effects 0.000 title abstract 2
- 230000003217 anti-cancerogenic effect Effects 0.000 title abstract 2
- 239000003963 antioxidant agent Substances 0.000 title abstract 2
- 230000003078 antioxidant effect Effects 0.000 title abstract 2
- 238000000034 method Methods 0.000 title abstract 2
- 239000007788 liquid Substances 0.000 abstract 5
- 239000003814 drug Substances 0.000 abstract 4
- 239000000654 additive Substances 0.000 abstract 2
- 238000002347 injection Methods 0.000 abstract 2
- 239000007924 injection Substances 0.000 abstract 2
- 101000798114 Homo sapiens Lactotransferrin Proteins 0.000 abstract 1
- 239000013543 active substance Substances 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 239000003889 eye drop Substances 0.000 abstract 1
- 229940012356 eye drops Drugs 0.000 abstract 1
- 102000050459 human LTF Human genes 0.000 abstract 1
- 238000010253 intravenous injection Methods 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
- 239000002674 ointment Substances 0.000 abstract 1
- 239000006187 pill Substances 0.000 abstract 1
- 239000000829 suppository Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/40—Transferrins, e.g. lactoferrins, ovotransferrins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Epidemiology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AU2001277824A AU2001277824A1 (en) | 2000-07-13 | 2001-07-09 | Antibacterial, antioxidant, immunomoduling and anticancerogenic preparation and method for using said preparation |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
RU2000118424/14A RU2165769C1 (ru) | 2000-07-13 | 2000-07-13 | Антибактериальный, антиоксидантный, иммуномодулирующий и антиканцерогенный препарат и способ его применения |
RU2000118424 | 2000-07-13 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2002003910A2 WO2002003910A2 (fr) | 2002-01-17 |
WO2002003910A3 true WO2002003910A3 (fr) | 2002-06-20 |
Family
ID=20237690
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/RU2001/000276 WO2002003910A2 (fr) | 2000-07-13 | 2001-07-09 | Preparation antibacterienne, anticancerigene, antioxydante et immunomodulatrice et procede d'utilisation |
Country Status (3)
Country | Link |
---|---|
AU (1) | AU2001277824A1 (fr) |
RU (1) | RU2165769C1 (fr) |
WO (1) | WO2002003910A2 (fr) |
Families Citing this family (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6399570B1 (en) | 1999-02-05 | 2002-06-04 | Agennix, Inc. | Antimicrobial/endotoxin neutralizing polypeptide |
RU2194501C1 (ru) * | 2001-06-18 | 2002-12-20 | Государственное образовательное учреждение высшего профессионального образования Санкт-Петербургская государственная медицинская академия им. И.И. Мечникова | Способ повышения резервуарной функции мочевого пузыря при хроническом цистите |
ATE519499T1 (de) | 2002-05-10 | 2011-08-15 | Agennix Inc | Lactoferrin bei der behandlung maligner neoplasien und anderer hyperproliferativer erkrankungen |
JP4516844B2 (ja) | 2002-09-16 | 2010-08-04 | エイジェニックス インコーポレイテッド | 創傷の処置におけるラクトフェリン |
AU2003296447A1 (en) | 2002-12-10 | 2004-06-30 | Agennix Incorporated | Lactoferrin as an agent in the prevention of organ transplant rejection and graft-versus-host-disease |
US7323443B2 (en) | 2002-12-12 | 2008-01-29 | Agennix Inc. | Lactoferrin in the reduction of pain |
WO2004103285A2 (fr) | 2003-05-14 | 2004-12-02 | Agennix Incorporated | Lactoferrine pour traitement du diabete sucre |
AU2004289170B2 (en) | 2003-06-06 | 2009-12-17 | Agennix Incorporated | Lactoferrin as an adjuvant in cancer vaccines |
WO2006047744A2 (fr) | 2004-10-26 | 2006-05-04 | Agennix Incorporated | Compositions de peptides en rapport avec la lactoferrine et utilisations |
RU2360678C1 (ru) * | 2008-01-30 | 2009-07-10 | Сергей Георгиевич Павленко | Способ лечения раневых поверхностей |
RU2421192C1 (ru) * | 2010-03-09 | 2011-06-20 | Винера Гумаровна Нафикова | Способ лечения хронического бактериального конъюнктивита |
BR112013012811B8 (pt) | 2010-11-26 | 2022-07-05 | Evonik Roehm Gmbh | Peptídeo derivado de lactoferrina humana, e processo para preparação de uma composição farmacêutica para liberação de uma substância ativa biológica em um organismo mamífero |
EP2481751A1 (fr) * | 2011-01-26 | 2012-08-01 | PharmaSurgics in Sweden AB | Homme peptides dérivés de lactoferrine |
RU2488406C1 (ru) * | 2012-02-16 | 2013-07-27 | Общество с ограниченной ответственностью "НТфарма" | Фармацевтическая композиция для терапии острых токсических состояний |
RU2687969C1 (ru) * | 2018-03-02 | 2019-05-17 | Федеральное государственное бюджетное учреждение науки Институт биологии гена Российской академии наук | Антимикробное средство |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5543392A (en) * | 1992-07-29 | 1996-08-06 | Morinaga Milk Industry Co., Ltd. | Digestive tract cell activating agent of EGF and lactoferrin |
RU95102930A (ru) * | 1995-02-28 | 1997-06-10 | Московский научно-исследовательский онкологический институт им.П.А.Герцена | Средство для лечения ревматоидных артритов |
RU2099065C1 (ru) * | 1994-09-23 | 1997-12-20 | Московский научно-исследовательский онкологический институт им. П.А.Герцена МЗ РФ | Препарат для лечения местных осложнений консервативного противоопухолевого лечения в орофарингеальной зоне и способ лечения осложнений консервативного противоопухолевого лечения в орофарингеальной зоне |
WO1998044940A1 (fr) * | 1997-04-10 | 1998-10-15 | Agennix, Inc. | Utilisation de la lactoferrine dans le traitement des troubles induits par allergenes |
EP0955058A1 (fr) * | 1997-01-09 | 1999-11-10 | Morinaga Milk Industry Co., Ltd. | Comprimes de lactoferrine |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2294018A1 (fr) * | 1998-04-13 | 1999-10-21 | New England Medical Center Hospitals, Inc. | Methodes et compositions permettant d'inactiver des agents infectieux au moyen de lactoferrine et de molecules associees |
-
2000
- 2000-07-13 RU RU2000118424/14A patent/RU2165769C1/ru active
-
2001
- 2001-07-09 AU AU2001277824A patent/AU2001277824A1/en not_active Abandoned
- 2001-07-09 WO PCT/RU2001/000276 patent/WO2002003910A2/fr active Application Filing
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5543392A (en) * | 1992-07-29 | 1996-08-06 | Morinaga Milk Industry Co., Ltd. | Digestive tract cell activating agent of EGF and lactoferrin |
RU2099065C1 (ru) * | 1994-09-23 | 1997-12-20 | Московский научно-исследовательский онкологический институт им. П.А.Герцена МЗ РФ | Препарат для лечения местных осложнений консервативного противоопухолевого лечения в орофарингеальной зоне и способ лечения осложнений консервативного противоопухолевого лечения в орофарингеальной зоне |
RU95102930A (ru) * | 1995-02-28 | 1997-06-10 | Московский научно-исследовательский онкологический институт им.П.А.Герцена | Средство для лечения ревматоидных артритов |
EP0955058A1 (fr) * | 1997-01-09 | 1999-11-10 | Morinaga Milk Industry Co., Ltd. | Comprimes de lactoferrine |
WO1998044940A1 (fr) * | 1997-04-10 | 1998-10-15 | Agennix, Inc. | Utilisation de la lactoferrine dans le traitement des troubles induits par allergenes |
Also Published As
Publication number | Publication date |
---|---|
AU2001277824A1 (en) | 2002-01-21 |
RU2165769C1 (ru) | 2001-04-27 |
WO2002003910A2 (fr) | 2002-01-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2002003910A3 (fr) | Preparation antibacterienne, anticancerigene, antioxydante et immunomodulatrice et procede d'utilisation | |
WO2006039704A3 (fr) | Composition pharmaceutique et methode de traitement d'une arthropathie a capsule articulaire | |
WO2002017881A3 (fr) | Composition d'administration transdermique d'agent pharmaceutique | |
EP1576963A3 (fr) | Utilisation d'une toxine botulinique pour le traitement de la douleur due à une infection | |
WO2003039436A3 (fr) | Compositions pharmaceutiques contenant de l'oxybutine | |
IL171607A (en) | Use of botulinum toxin for the treatment of sinusitis-induced headaches | |
WO2008062440A3 (fr) | Technique de libération programmable par système flottant | |
EP1772767A3 (fr) | Procédé pour la formation de lentilles de contact comprenant des agents thérapeutiques | |
BR0109875A (pt) | Tratamento de doenças respiratórias | |
WO2003059318A3 (fr) | Tampon medicamente | |
EP1283054A4 (fr) | Medicaments permettant de traiter les complications du diabete et des neuropathies et utilisation de ces medicaments | |
WO2005058233A3 (fr) | Methodes de traitement d'une pancreatite aigue | |
WO2007075695A3 (fr) | Utilisation de derives de sulfamide heterocyclique benzo-fusionne pour le traitement de la manie et du trouble bipolaire | |
WO2005007072A3 (fr) | Methodes et compositions pharmaceutiques pour cicatriser des lesions | |
CA2454976A1 (fr) | Agent therapeutique contre le glaucome contenant en tant qu'ingre dient actif un compose presentant un effet inhibiteur de la kinase pi3 | |
WO2001030380A3 (fr) | Techniques et compositions destinees au traitement du keratocone au moyen d'inhibiteurs de protease | |
AU2002211536A1 (en) | Compositions for injection or intravenous administration for the treatment of internal infection or inflammation in humans and animals | |
WO2001091774A3 (fr) | Traitement des ulceres chroniques | |
WO2005094836A3 (fr) | Utilisation de loteprednol etabonate pour le traitement des yeux secs | |
CA2433833A1 (fr) | Utilisation de flumazenil dans l'elaboration d'un medicament visant a traiter la dependence a l'alcool | |
WO2001024783A3 (fr) | Utilisation de (+)-tramadol, de o-demethyltramadol ou de (+)-o-demethyltramadol, de o-desmethyle-n-mono-desmethyl-tramadol ou de (+)o-desmethyl-n-mono-desmethyl-tramadol pour traiter l'incontinence urinaire | |
WO2001081332A3 (fr) | Composes de 2-fluorobenzenesulfonyle utilises pour le traitement d'inflammations | |
WO2006138571A3 (fr) | Composition et procede d'inhibition, de prevention ou d'amelioration des complications associees a l'ingestion d'une substance ou d'un agent medicinal, chimique ou biologique | |
WO2002053090A3 (fr) | Association medicamenteuse d'une biguanine (metformine) et d'arginine | |
WO2006050002A3 (fr) | Compositions destinees a l'administration controlee de composes pharmaceutiquement actifs |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AL AM AT AU AZ BA BB BG BR BY CA CH CN CU CZ DE DK EE ES FI GB GE GH GM HU ID IL IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO SD SE SG SI SK SL TJ TM TR TT UA UG US UZ VN YU ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
AK | Designated states |
Kind code of ref document: A3 Designated state(s): AL AM AT AU AZ BA BB BG BR BY CA CH CN CU CZ DE DK EE ES FI GB GE GH GM HU ID IL IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO SD SE SG SI SK SL TJ TM TR TT UA UG US UZ VN YU ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A3 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG |
|
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
REG | Reference to national code |
Ref country code: DE Ref legal event code: 8642 |
|
122 | Ep: pct application non-entry in european phase | ||
NENP | Non-entry into the national phase |
Ref country code: JP |